Last $97.84 USD
Change Today -0.29 / -0.30%
Volume 366.4K
MNK On Other Exchanges
Symbol
Exchange
New York
As of 5:15 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Christopher Trudeau

Chief Executive Officer, President, Director and Member of Portfolio Committee, Mallinckrodt public limited company
AgeTotal Calculated CompensationThis person is connected to 41 board members in 2 different organizations across 4 different industries.

See Board Relationships
53$11,040,789
As of Fiscal Year 2013

Background*

Mr. Mark Christopher Trudeau has been Chief Executive Officer and President of Mallinckrodt Plc (alternate name: The Pharmaceuticals business of Covidien plc) since June 2013. Mr. Trudeau was joined Covidien plc as Senior Vice President and President of Pharmaceuticals Segment in February 1, 2012. He was joined Covidien from Bayer HealthCare Pharmaceuticals LLC USA, the U.S. healthcare business of Bayer AG, where he served as Chief Executive Officer. He simultaneously ...

Read Full Background

Corporate Headquarters*

Damastown Industrial Estate
Dublin, Co. Dublin 15

Ireland

Phone: 353 1 880 8180
Fax: --

Board Members Memberships*

2013-Present
Trustee
2013-Present
Chief Executive Officer, President, Director and Member of Portfolio Committee

Education*

Bachelor's Degree
University of Michigan
MBA
University of Michigan

Other Affiliations*

Annual Compensation*

Salary$723,942
Bonus$100,000
Total Annual Compensation$823,942

Stock Options*

Restricted Stock Awards$4,315,055
All Other Compensation$84,347
Exercisable Options17,904
Exercisable Options Value$102,411
Unexercisable Options365,899
Unexercisable Options Value$450,293
Total Value of Options$552,703
Total Number of Options383,803

Total Compensation*

Total Annual Cash Compensation$1,793,853
Total Short Term Compensation$823,942
Other Long Term Compensation$4,399,402
Total Calculated Compensation$11,040,789
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNK:US $97.84 USD -0.29

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$4.3M
Yves L'epine Chief Executive Officer, Director and Member of Strategy & Innovation Committee
Guerbet SA
€370.8K
Olivier Legrain Chief Executive Officer, President, Director and Member of Nomination Committee
Ion Beam Applications, S.A.
€615.0K
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MALLINCKRODT PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.